- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07594730
Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems
RCT of Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems
The goal of this study is to test the efficacy of brief video interventions parental internalized stigma and stigma-related outcomes (e.g., treatment intentions, caregiver burden, secrecy) among parents (ages 25-50) of children ages 6-18 with depression, ADHD, or substance use problems.
Timely identification and treatment of mental health problems in youth is a public health priority. However, many youth do not receive treatment, and stigma has been identified as the primary barrier to help-seeking. Parents experience stigma related to their children having mental health problems, which has been associated with reduced help-seeking and increased parental distress. Prior experiments have found brief video-based interventions (BVIs), 1-2 minute videos similar to those viewed by youth on social media platforms, based on the principle of "social contact" with individuals affected by a stigmatized condition, effective in reducing mental health stigma and increasing help-seeking.
In this 4-arm RCT, the investigators will recruit parents aged 25-50 using an online crowdsourcing platform, to test the efficacy of BVIs featuring a personal parent narrative of their experience with their child's a) depression, b) ADHD, or c) substance use, or d) a control condition that provides general written psychoeducational information without social contact.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Brief video-based interventions (BVIs) have been studied as a means of reducing stigma toward mental health problems and increasing help-seeking. "Contact-based interventions," in which a representative of a stigmatized group shares their personal stories, have been found one of the most effective anti-stigma interventions. Effective contact-based interventions target to a specific population, account for the specific interests of that population, and credibly provide stories that highlight recovery in a plausible manner to moderately disconfirm stereotypes. BVIs package contact-based stigma interventions into short (1-2 minute) messages in the style of social media content. Prior RCTs have tested BVIs targeting depression-related stigma in adolescents, featuring a young person describing experiences with depressive symptoms, that improved as they sought support from parents and professionals. Parents often experience stigma to their children's mental health problems and play a critical gate-keeping role for children accessing mental health treatment. Additionally, parental stigma is associated with child mental health outcomes, and potential mediators between parental stigma and child outcomes including parental wellbeing, attitudes toward the child, help-seeking, and self-efficacy. Thus, the investigators hypothesize that BVIs targeted to parents of children with similar mental health conditions (e.g., depression, ADHD, or substance use) will have greater impact on reducing stigma and increasing treatment intentions than generic written psychoeducational content without a social contact component.
This study will measure distinct stigma-related outcomes relevant to parents of children with mental health problems:
- Parental internalized stigma
- Treatment intentions
- Treatment engagement
- Attitudes toward the child
- Caregiver burden
- Self-efficacy
- secrecy coping (i.e., to avoid potential negative repercussions of stigma).
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Doron Amsalem, MD
- Número de teléfono: 929-404-8802
- Correo electrónico: doron.amsalem@nyspi.columbia.edu
Copia de seguridad de contactos de estudio
- Nombre: Timothy Becker, MD
- Número de teléfono: 914-997-5203
- Correo electrónico: tdb2143@cumc.columbia.edu
Ubicaciones de estudio
-
-
New York
-
New York, New York, Estados Unidos, 10032
- Columbia University Irving Medical Center
-
Contacto:
- Doron Amsalem, MD
- Número de teléfono: 929-404-8802
- Correo electrónico: doron.amsalem@nyspi.columbia.edu
-
Contacto:
- Timothy Becker, MD
- Número de teléfono: 914-997-5203
- Correo electrónico: tdb2143@cumc.columbia.edu
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Self-identify as English Speaking
- Live in the US
- Ages 25-50
- Have a child 6-18 years old with either depression, ADHD, or a substance use problem
Exclusion Criteria:
- Do not speak English
- Do not live in the US
- <25 or >50
- Do not have a child between ages 6-18 with depression, ADHD, or a substance use problem
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental: Depression social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's depression, impact of the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Experimental: Experimental: ADHD social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's ADHD, impact on the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Experimental: Experimental: substance use social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's depression, impact on the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Sin intervención: Control
Written psychoeducational information about children's mental health, treatment options, and how parents can support child
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Parental Internalized Stigma of Mental Illness scale (PISMI)
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
Measures internalized stigma among parents of children with mental health problems; scores range 12-48; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form (adapted)
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
3-item measure of treatment intentions, modified for parents of children with mental health problems; scores range 0-9; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Zarit Burden Interview screen
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
Brief measure of caregiver burden; scores range 0-16; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Secrecy coping scale (adapted)
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
Parental attitudes toward concealing the child's problems from others; scores range 4-24; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Parental self-efficacy
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
Single item measure from Parenting sense of competence (PSOC) scale; scores range 1-6; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Parental attitudes and responses toward adolescent depression (adapted)
Periodo de tiempo: Immediately after viewing video, 30 days after intervention
|
Select items measuring critical and supportive responses to child's emotional needs; scores range 0-32; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Treatment engagement
Periodo de tiempo: 30 days after intervention
|
3 questions about considering treatment, taking steps to start treatment, or starting treatment in the prior 30 days; yes/no categorical responses - no minimum or maximum values
|
30 days after intervention
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Doron Amsalem, MD, Columbia University; New York State Psychiatric Institute
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Desordenes mentales
- Síntomas de comportamiento
- Trastornos inducidos químicamente
- Trastornos del neurodesarrollo
- Estrés Psicológico
- Trastornos por Déficit de Atención y Conducta Disruptiva
- Comportamiento
- Comportamiento social
- Carga del cuidador
- Trastornos relacionados con sustancias
- Trastorno por Déficit de Atención con Hiperactividad
- Estigma social
- Comportamiento de búsqueda de ayuda
Otros números de identificación del estudio
- AAAV7555
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .